Software Experts has released a new editorial assessment examining how modern vector design tools support real world production needs across print, marketing, and apparel workflows. In its latest ...

The first vector-delivered gene therapies to receive FDA approval for clinical use were Luxturna,1 Spark Therapeutics’ vision loss cure, and Zolgensma,2 Novartis’ spinal muscular atrophy treatment.

Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Markets and Technologies Through 2030" report has been added to ResearchAndMarkets.com's offering. The global market for viral ...

Bristol Myers Squibb’s cancer cell therapy Breyanzi. Johnson & Johnson and AstraZeneca’s recombinant COVID-19 vaccines. Novartis’ gene therapy Zolgensma. All of these, plus many others, are united by ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Developers can now leverage the robustness and reliability of PostgreSQL for AI while minimizing operational complexity, increasing efficiency and achieving faster search speeds Timescale, the cloud ...

Despite the aggressive cost claims and dramatic scale improvements, AWS is positioning S3 Vectors as a complementary storage tier rather than a direct replacement for specialized vector databases.